This study is looking at whether using a continuous glucose monitor (CGM) can help detect and manage high blood sugar early in pregnancy. You could be eligible if you are a woman aged 18 or older, are pregnant with one baby, and are up to 14 weeks and 6 days into your pregnancy. The study aims to see if using CGM helps prevent problems for the baby, such as being too large or having low blood sugar, and for the mother, like high blood pressure during pregnancy. Some participants will use an unblinded CGM and receive special nutrition information, while others will receive usual care and wear a blinded CGM periodically. The study plans to enroll 6000 participants.

Study design

This interventional study plans to enroll 6000 participants and compares two groups: one using an unblinded CGM with specific nutrition guidance, and another receiving usual care with a blinded CGM.

What's involved

You would wear a CGM sensor, either unblinded 24/7 or blinded for 10-14 days at routine visits. You would also receive either specific or general pregnancy nutrition information.

Compensation

Not stated in the trial record.

Follow-up

Your health will be monitored from the start of the study until 45 weeks of pregnancy to track any neonatal complications or maternal hypertensive disorders.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.